HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shiseido acquires Joico

This article was originally published in The Rose Sheet

Executive Summary

Japanese cosmetics firm is expanding U.S. professional business with acquisition of Joico Laboratories, a Los Angeles, Calif. salon hair care manufacturer, Shiseido announces Dec. 28. Joico will operate under Shiseido's wholly-owned professional subsidiary, Zotos International, the company said. Move marks Shiseido's fourth acquisition in the U.S. salon sector; firm purchased Zotos and Lamaur's professional products in 1988 and Helene Curtis Professional in 1996. Joico was founded by President and CEO Steve Stefano 25 years ago. Brands within the company's product portfolio include Joico, I.C.E. Hair, Vero and Triactive...

You may also be interested in...



Shiseido Men Skin Care Launch Aims To Revive Sales

Shiseido Men is positioned as a "highly functional" prestige skin care range that addresses everyday stressors, according to the Japanese beauty firm

The Quality Lowdown: On Redeploying Inspectors, API Suppliers Thanks To Coronavirus

US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.

Mallinckrodt's Opioid Resolution Through Generic Unit Bankruptcy May Be 'Test Case'

Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.

UsernamePublicRestriction

Register

RS009931

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel